Literature DB >> 11720788

An adenosine A2a agonist increases sleep and induces Fos in ventrolateral preoptic neurons.

T E Scammell1, D Y Gerashchenko, T Mochizuki, M T McCarthy, I V Estabrooke, C A Sears, C B Saper, Y Urade, O Hayaishi.   

Abstract

Considerable evidence indicates that adenosine may be an endogenous somnogen, yet the mechanism through which it promotes sleep is unknown. Adenosine may act via A1 receptors to promote sleep, but an A2a receptor antagonist can block the sleep induced by prostaglandin D(2). We previously reported that prostaglandin D(2) activates sleep-promoting neurons of the ventrolateral preoptic area, and we hypothesized that an A2a receptor agonist also should activate these neurons. Rats were instrumented for sleep recordings, and an injection cannula was placed in the subarachnoid space just anterior to the ventrolateral preoptic area. After an 8-10-day recovery period, the A2a receptor agonist CGS21680 (20 pmol/min) or saline was infused through the injection cannula, and the animals were killed 2 h later. The brains were stained using Fos immunohistochemistry, and the pattern of Fos expression was studied in the entire brain. CGS21680 increased non-rapid eye movement sleep and markedly increased the expression of Fos in the ventrolateral preoptic area and basal leptomeninges, but it reduced Fos expression in wake-active brain regions such as the tuberomammillary nucleus. CGS21680 also induced Fos in the shell and core of the nucleus accumbens and in the lateral subdivision of the central nucleus of the amygdala. To determine whether these effects may have been mediated through A1 receptors, an additional group of rats received subarachnoid infusion of the A1 receptor agonist N(6)-cyclopentyladenosine (2 pmol/min). In contrast to CGS21680, infusion of N(6)-cyclopentyladenosine into the subarachnoid space produced only a small decrease in rapid eye movement sleep, and the pattern of Fos expression induced by N(6)-cyclopentyladenosine was notable only for decreased Fos in regions near the infusion site. These findings suggest that an adenosine A2a receptor agonist may activate cells of the leptomeninges or nucleus accumbens that increase the activity of ventrolateral preoptic area neurons. These ventrolateral preoptic area neurons may then coordinate the inhibition of multiple wake-promoting regions, resulting in sleep.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11720788     DOI: 10.1016/s0306-4522(01)00383-9

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  61 in total

1.  Sleep-waking discharge patterns of median preoptic nucleus neurons in rats.

Authors:  Natalia Suntsova; Ronald Szymusiak; Md Noor Alam; Ruben Guzman-Marin; Dennis McGinty
Journal:  J Physiol       Date:  2002-09-01       Impact factor: 5.182

2.  Polymorphisms of ADORA2A modulate psychomotor vigilance and the effects of caffeine on neurobehavioural performance and sleep EEG after sleep deprivation.

Authors:  S Bodenmann; C Hohoff; C Freitag; J Deckert; J V Rétey; V Bachmann; H-P Landolt
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

3.  Essential role of dopamine D2 receptor in the maintenance of wakefulness, but not in homeostatic regulation of sleep, in mice.

Authors:  Wei-Min Qu; Xin-Hong Xu; Ming-Ming Yan; Yi-Qun Wang; Yoshihiro Urade; Zhi-Li Huang
Journal:  J Neurosci       Date:  2010-03-24       Impact factor: 6.167

4.  Mathematical model of network dynamics governing mouse sleep-wake behavior.

Authors:  Cecilia G Diniz Behn; Emery N Brown; Thomas E Scammell; Nancy J Kopell
Journal:  J Neurophysiol       Date:  2007-04-04       Impact factor: 2.714

Review 5.  Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry implications for drug addiction, sleep and pain.

Authors:  S Ferré; I Diamond; S R Goldberg; L Yao; S M O Hourani; Z L Huang; Y Urade; I Kitchen
Journal:  Prog Neurobiol       Date:  2007-05-01       Impact factor: 11.685

6.  Neuronal activity in the preoptic hypothalamus during sleep deprivation and recovery sleep.

Authors:  Md Aftab Alam; Sunil Kumar; Dennis McGinty; Md Noor Alam; Ronald Szymusiak
Journal:  J Neurophysiol       Date:  2013-10-30       Impact factor: 2.714

Review 7.  The energy hypothesis of sleep revisited.

Authors:  Matthew T Scharf; Nirinjini Naidoo; John E Zimmerman; Allan I Pack
Journal:  Prog Neurobiol       Date:  2008-09-03       Impact factor: 11.685

Review 8.  Sleep neurobiology from a clinical perspective.

Authors:  Rodrigo A España; Thomas E Scammell
Journal:  Sleep       Date:  2011-07-01       Impact factor: 5.849

Review 9.  About sleep's role in memory.

Authors:  Björn Rasch; Jan Born
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

10.  Systemic administration of the adenosine A(2A) agonist CGS 21680 induces sedation at doses that suppress lever pressing and food intake.

Authors:  Susana Mingote; Mariana Pereira; Andrew M Farrar; Peter J McLaughlin; John D Salamone
Journal:  Pharmacol Biochem Behav       Date:  2008-01-17       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.